Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of human CD4 + T cell populations with distinct antitumor activity

1 Jul 2020

Abstract excerpt

Human CD4 + T cell subsets elicit differential immunity against solid tumors when redirected with antigen specificity.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CAR-T cell therapy research
Share to Immunotherapy and Immune Responses
Share to T-cell and B-cell Immunology

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 32937437
DOI: 10.1126/sciadv.aba7443

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of human CD4 + T cell populations with distinct antitumor activityPMID 32937437Read ↗

Expanding Roles for CD4 T Cells and Their Subpopulations in Tumor Immunity and TherapySemantic proximity Read ↗

Tumor antigen‐specific CD4 + T cells in cancer immunity: from antigen identification to tumor prognosis and development of therapeutic strategiesSemantic proximity Read ↗

Focusing on CD8+ T-cell phenotypes: improving solid tumor therapy.Semantic proximity Read ↗

The repertoire of human tumor-associated epitopes — identification and selection of antigens and their application in clinical trialsSemantic proximity Read ↗

Consensus nomenclature for CD8+T cell phenotypes in cancerSemantic proximity Read ↗

T Cell Recognition of Human Tumors: Implications for Molecular Immunotherapy of CancerSemantic proximity Read ↗

The outstanding antitumor capacity of CD4+ T helper lymphocytesSemantic proximity Read ↗

Contrasting cytotoxic and regulatory T cell responses underlying distinct clinical outcomes to anti-PD-1 plus lenvatinib therapy in cancerSemantic proximity Read ↗

Bystander CD4 + T cells infiltrate human tumors and are phenotypically distinctSemantic proximity Read ↗

Cytotoxic CD4+ T cells in cancer: Expanding the immune effector toolboxSemantic proximity Read ↗

Organoid-T cell co-cultures functionally stratify tumor-reactive T cells and their responses to immune checkpoint inhibitorsSemantic proximity Read ↗

CD39 Identifies the CD4+ Tumor-Specific T-cell Population in Human CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.